Scalper1 News
Biotechs are getting hit hard on the stock market today. The group has been the No. 1 group out of IBD’s 197 industries, but it’s on track for its worst weekly decline in about a year. Some top-rated biotech stocks taking a beating include Celgene (CELG), Biogen (BIIB) and Regeneron (REGN). Watch this video for IBD chart analysis of each stock. Follow Alissa Williams on Twitter: @IBD_AWilliams. Scalper1 News
Scalper1 News